We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

137 hedge funds and large institutions have $914M invested in Cardiovascular Systems, Inc. in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 46 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 12

51% more capital invested

Capital invested by funds: $604M → $914M (+$310M)

7% more funds holding

Funds holding: 128137 (+9)

6% more call options, than puts

Call options by funds: $2.37M | Put options by funds: $2.23M

2% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 46

Holders
137
Holders Change
+9
Holders Change %
+7.03%
% of All Funds
3.12%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
45
Reduced
46
Closed
12
Calls
$2.37M
Puts
$2.23M
Net Calls
+$140K
Net Calls Change
+$151K

CSII Hedge Fund Activity: Q2 2018 in Review

137 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2018, worth a combined $914M — up 51% from $604M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new CSII positions and 12 closed out — a net gain of 9 holders — while 45 added to existing stakes and 46 trimmed.

The largest buyer was Camber Capital Management, adding an estimated $11.3M. The largest seller was Wellington Management Group, cutting an estimated $20M.

  • 137 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2018, up from 128 in Q1 2018.
  • Funds reported $914M of Cardiovascular Systems, Inc. stock for Q2 2018, up 51% quarter-over-quarter.
  • 21 funds opened new Cardiovascular Systems, Inc. positions in Q2 2018 and 12 closed out, a net change of +9 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q2 2018 was Camber Capital Management, an estimated $11.3M added.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2018 was Wellington Management Group, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2018.